Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2019-03-14 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
유상증자최종발행가액확정
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the finalization of the issue price for a capital increase (paid-in capital increase/rights offering) for the company Genomictree. It specifies the number of shares, the final price per share, and the date of determination. This falls under the category of share issuance and capital changes.
2019-03-14 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 95% confidence The document is a short, structured announcement reporting the results of an Investor Relations (IR) meeting held by Genomictree. It provides details such as the date, location, attendees, and a summary of the topics discussed (company status, management outlook, Q&A). It does not contain the full presentation slides or detailed financial reports, but rather serves as a formal notification of the event's occurrence and outcome. Given its nature as a regulatory disclosure of an event, it fits best under the 'Regulatory Filings' category as it is a standard corporate disclosure of an IR event result.
2019-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Genomictree. It contains the agenda for the meeting, including the approval of financial statements, appointment of auditors, and other corporate governance matters. It also includes detailed management information, business overviews, and board activity reports typically found in proxy materials sent to shareholders to solicit votes for an upcoming AGM. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2019-03-08 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal notification filed by Genomictree regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the internal and external reasons for this scheduling choice. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or the results of the meeting, it falls under the general regulatory filing category.
2019-03-08 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 90% confidence The document is an official announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides details such as date, time, location, and purpose (listing on KOSDAQ). Since this is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Investor Presentation' (which would contain the actual slides) or 'Report Publication Announcement' (which usually refers to financial reports), it is best classified as a general regulatory filing or announcement regarding corporate activities.
2019-03-07 Korean
투자설명서
Regulatory Filings Classification · 98% confidence The document is a '투자설명서' (Investment Prospectus) for Genomictree, Inc. It contains detailed information regarding a public offering of shares, including offering price, subscription periods, risk factors, and financial disclosures. This is a formal regulatory document filed with the Financial Supervisory Service (FSS) in South Korea to provide potential investors with necessary information for a securities offering. Among the provided categories, 'Proxy Solicitation & Information Statement' (PSI) is the closest fit for a prospectus document that provides detailed information to shareholders/investors for a specific corporate action, although it is technically a securities registration statement.
2019-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.